Marijke Reynders

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe et al. · Clinical Microbiology and Infection · 2021 · 219 citations · Full text

Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1

Nico Janssen, Rémy Nyga, Lore Vanderbeke et al. · Emerging infectious diseases · 2021 · 136 citations · Full text

Covid-19–associated Pulmonary Aspergillosis1, Clinical Epidemiology, Several Factors +9

EFFICACY OF HEAT-INACTIVATED HEPATITIS B VACCINE IN HAEMODIALYSIS PATIENTS AND STAFF

Jan Desmyter, Guy De Groote, J. Colaert et al. · The Lancet · 1983 · 121 citations

Vaccination, Hemodialysis, Viral Hepatitis +5

Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study

Jens Van Praet, Marijke Reynders, Dirk De Bacquer et al. · Journal of the American Society of Nephrology · 2021 · 94 citations · Full text

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial

Lore Vanderbeke, Nico Janssen, Dennis C. J. J. Bergmans et al. · Intensive Care Medicine · 2021 · 91 citations · Full text

Proof-of-concept Trial, Antifungal Agent, Ill Influenza Patients +7